OQS
VYGR icon

Occudo Quantitative Strategies’s Voyager Therapeutics VYGR Stock Holding History

Occudo Quantitative Strategies’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,998
Closed -$77.7K – 892
2025
Q2 		$77.7K Buy
+24,998
New +$80.6K 0.01% 584
2022
Q4 		– Sell
-26,593
Closed -$157K – 1412
2022
Q3 		$157K Sell
26,593
-9,559
-26% -$61.2K 0.01% 993
2022
Q2 		$214K Buy
36,152
+21,759
+151% +$147K 0.02% 894
2022
Q1 		$110K Buy
+14,393
New +$64.2K 0.01% 1013
2021
Q4 		– Sell
-16,069
Closed -$42K – 1268
2021
Q3 		$42K Sell
16,069
-5,265
-25% -$17.1K 0.01% 976
2021
Q2 		$88K Buy
+21,334
New +$96.7K 0.01% 802

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Occudo Quantitative Strategies's VYGR Position: Q3 2025 in Review

Occudo Quantitative Strategies sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 24,998 shares — an estimated $77.7K sold.

Occudo Quantitative Strategies first reported a position in VYGR in Q2 2021 and held it in 6 quarters. The position peaked at $214K in Q2 2022. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • Occudo Quantitative Strategies reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 24,998 Voyager Therapeutics shares in Q3 2025, an estimated $77.7K.
  • Occudo Quantitative Strategies first reported a position in Voyager Therapeutics in Q2 2021 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Voyager Therapeutics position peaked at $214K in Q2 2022.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.